BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bian ZX, Li Z, Huang ZX, Zhang M, Chen HL, Xu HX, Sung JJ. Unbalanced expression of protease-activated receptors-1 and -2 in the colon of diarrhea-predominant irritable bowel syndrome patients. J Gastroenterol. 2009;44:666-674. [PMID: 19430717 DOI: 10.1007/s00535-009-0058-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Decraecker L, Boeckxstaens G, Denadai-souza A. Inhibition of Serine Proteases as a Novel Therapeutic Strategy for Abdominal Pain in IBS. Front Physiol 2022;13:880422. [DOI: 10.3389/fphys.2022.880422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 De Bruyn M, Ceuleers H, Hanning N, Berg M, De Man JG, Hulpiau P, Hermans C, Stenman UH, Koistinen H, Lambeir AM, De Winter BY, De Meester I. Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-Colitis. Int J Mol Sci 2021;22:10711. [PMID: 34639054 DOI: 10.3390/ijms221910711] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Friesen H, Singh M, Singh V, Schurman JV, Friesen CA. A Survey of Methodologies for Assessing Mast Cell Density and Activation in Patients with Functional Abdominal Pain Disorders. GastrointestDisord 2021;3:142-55. [DOI: 10.3390/gidisord3040016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Choo J, Heo G, Pothoulakis C, Im E. Posttranslational modifications as therapeutic targets for intestinal disorders. Pharmacol Res 2021;165:105412. [PMID: 33412276 DOI: 10.1016/j.phrs.2020.105412] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Aguilera-Lizarraga J, Florens MV, Van Brussel T, Clevers E, Van Oudenhove L, Lambrechts D, Wouters MM, Boeckxstaens GE. Expression of immune-related genes in rectum and colon descendens of Irritable Bowel Syndrome patients is unrelated to clinical symptoms. Neurogastroenterol Motil 2019;31:e13579. [PMID: 30854791 DOI: 10.1111/nmo.13579] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
6 Sung TS, Lu H, Sung J, Yeom JH, Perrino BA, Koh SD. The functional role of protease-activated receptors on contractile responses by activation of Ca(2+) sensitization pathways in simian colonic muscles. Am J Physiol Gastrointest Liver Physiol 2018;315:G921-31. [PMID: 30260688 DOI: 10.1152/ajpgi.00255.2018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Lazaridis N, Germanidis G. Current insights into the innate immune system dysfunction in irritable bowel syndrome. Ann Gastroenterol 2018;31:171-87. [PMID: 29507464 DOI: 10.20524/aog.2018.0229] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
8 Liang WJ, Zhang G, Luo HS, Liang LX, Huang D, Zhang FC. Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome. Gut Liver. 2016;10:382-390. [PMID: 26446924 DOI: 10.5009/gnl14319] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
9 段园志, 唐旭东, 王凤云, 马祥雪. PAR-2信号通路与功能性胃肠病. 世界华人消化杂志 2017; 25(13): 1159-1165 [DOI: 10.11569/wcjd.v25.i13.1159] [Reference Citation Analysis]
10 Ceuleers H, Van Spaendonk H, Hanning N, Heirbaut J, Lambeir AM, Joossens J, Augustyns K, De Man JG, De Meester I, De Winter BY. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases. World J Gastroenterol 2016; 22(47): 10275-10286 [PMID: 28058009 DOI: 10.3748/wjg.v22.i47.10275] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
11 Lee EH, Yang HR, Lee HS. Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil 2016;22:459-69. [PMID: 27053514 DOI: 10.5056/jnm15174] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhang L, Song J, Hou X. Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside. J Neurogastroenterol Motil. 2016;22:181-192. [PMID: 26755686 DOI: 10.5056/jnm15137] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 11.6] [Reference Citation Analysis]
13 Farmer AD, Aziz Q. Gut pain & visceral hypersensitivity. Br J Pain. 2013;7:39-47. [PMID: 26516496 DOI: 10.1177/2049463713479229] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
14 Graziottin A, Gambini D, Bertolasi L. Genital and sexual pain in women. Neurology of Sexual and Bladder Disorders 2015. [DOI: 10.1016/b978-0-444-63247-0.00023-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
15 Distrutti E, Cipriani S, Mencarelli A, Renga B, Fiorucci S. Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. PLoS One. 2013;8:e63893. [PMID: 23691109 DOI: 10.1371/journal.pone.0063893] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 8.0] [Reference Citation Analysis]
16 Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther 2012;36:1009-31. [PMID: 23066886 DOI: 10.1111/apt.12080] [Cited by in Crossref: 143] [Cited by in F6Publishing: 134] [Article Influence: 13.0] [Reference Citation Analysis]
17 Chen CW, Chen QB, Ouyang Q, Sun JH, Liu FT, Song DW, Yuan HB. Transient early neurotrophin release and delayed inflammatory cytokine release by microglia in response to PAR-2 stimulation. J Neuroinflammation 2012;9:142. [PMID: 22731117 DOI: 10.1186/1742-2094-9-142] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
18 Anand P, Singh B, Jaggi AS, Singh N. Mast cells: an expanding pathophysiological role from allergy to other disorders. Naunyn Schmiedebergs Arch Pharmacol 2012;385:657-70. [PMID: 22562473 DOI: 10.1007/s00210-012-0757-8] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
19 Suckow SK, Anderson EM, Caudle RM. Lesioning of TRPV1 expressing primary afferent neurons prevents PAR-2 induced motility, but not mechanical hypersensitivity in the rat colon. Neurogastroenterol Motil 2012;24:e125-35. [PMID: 22168801 DOI: 10.1111/j.1365-2982.2011.01848.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
20 Han W, Wang Z, Lu X, Guo C. Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome. Neurogastroenterol Motil 2012;24:113-9, e82. [PMID: 22151913 DOI: 10.1111/j.1365-2982.2011.01841.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
21 Zhao JH, Dong L, Shi HT, Wang ZY, Shi HY, Ding H. The expression of protease-activated receptor 2 and 4 in the colon of irritable bowel syndrome patients. Dig Dis Sci 2012;57:58-64. [PMID: 21800160 DOI: 10.1007/s10620-011-1827-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
22 Mueller K, Michel K, Krueger D, Demir IE, Ceyhan GO, Zeller F, Kreis ME, Schemann M. Activity of protease-activated receptors in the human submucous plexus. Gastroenterology 2011;141:2088-2097.e1. [PMID: 21875497 DOI: 10.1053/j.gastro.2011.08.034] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
23 Ford AC, Talley NJ. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol. 2011;46:421-431. [PMID: 21331765 DOI: 10.1007/s00535-011-0379-9] [Cited by in Crossref: 126] [Cited by in F6Publishing: 137] [Article Influence: 10.5] [Reference Citation Analysis]
24 Malinen E, Krogius-Kurikka L, Lyra A, Nikkilä J, Jääskeläinen A, Rinttilä T, Vilpponen-Salmela T, Wright AJV, Palva A. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol 2010; 16(36): 4532-4540 [PMID: 20857523 DOI: 10.3748/wjg.v16.i36.4532] [Cited by in CrossRef: 145] [Cited by in F6Publishing: 152] [Article Influence: 11.2] [Reference Citation Analysis]